American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34(Suppl 1):S62–9. https://doi.org/10.2337/dc11-S062.
Article CAS PubMed Central Google Scholar
Holt RIG, DeVries JH, Hess-Fischl A, et al. The management of type 1 diabetes in adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2021;44(11):2589–625. https://doi.org/10.2337/dci21-0043.
Article CAS PubMed Google Scholar
Syed FZ. Type 1 diabetes Mellitus. Ann Intern Med. 2022;175(3):ITC33–48.
Chinese Diabetes Society, Association CE. Chinese Society of Endocrinology, Chinese Pediatric Society. Guidelines for the diagnosis and treatment of type 1 diabetes mellitus in China (2021 edition). Chin J Diabetes Mellitus. 2022;14(11):1143–250. https://doi.org/10.3760/cma.j.cn115791-20220916-00474.
Standards of medical care for patients with diabetes mellitus. Diabetes Care. 1989;12(5):365–68. https://doi.org/10.2337/diacare.12.5.365.
Wang M, Hng TM. HbA1c: more than just a number. Aust J Gen Pract. 2021;50(9):628–32. https://doi.org/10.2337/diacare.12.5.365.
Blair JC, McKay A, Ridyard C, et al. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation. BMJ. 2019;365:l1226. https://doi.org/10.1136/bmj.l1226.
Article PubMed PubMed Central Google Scholar
Pala L, Dicembrini I, Mannucci E. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials. Acta Diabetol. 2019;56(9):973–80. https://doi.org/10.1007/s00592-019-01326-5.
Article CAS PubMed Google Scholar
Speight J, Choudhary P, Wilmot EG, et al. Impact of glycaemic technologies on quality of life and related outcomes in adults with type 1 diabetes: a narrative review. Diabet Med. 2023;40(1):e14944. https://doi.org/10.1111/dme.14944.
Benioudakis E, Karlafti E, Kalaitzaki A, Kaiafa G, Savopoulos C, Didangelos T. Technological Developments and Quality of Life in Type 1 diabetes Mellitus patients: a review of the modern insulin analogues, continuous glucose monitoring and insulin pump therapy. Curr Diabetes Rev. 2022;18(7):e031121197657. https://doi.org/10.2174/1573399818666211103163208.
Article CAS PubMed Google Scholar
Benioudakis ES, Georgiou ED, Barouxi ED, et al. The diabetes quality of life brief clinical inventory in combination with the management strategies in type 1 diabetes mellitus with or without the use of insulin pump. Diabetol Int. 2020;12(2):217–28. https://doi.org/10.1007/s13340-020-00477-z.
Article PubMed PubMed Central Google Scholar
Khunti K, Alsifri S, Aronson R, et al. Rates and predictors of hypoglycaemia in 27585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study. Diabetes Obes Metab. 2016;18(9):907–15. https://doi.org/10.1111/dom.12689.
Article CAS PubMed PubMed Central Google Scholar
Böhme P, Bertin E, Cosson E, Chevalier N, GEODE group. Fear of hypoglycaemia in patients with type 1 diabetes: do patients and diabetologists feel the same way? Diabetes Metab. 2013;39(1):63–70. https://doi.org/10.1016/j.diabet.2012.10.006.
Martyn-Nemeth P, Quinn L, Penckofer S, Park C, Hofer V, Burke L. Fear of hypoglycemia: influence on glycemic variability and self-management behavior in young adults with type 1 diabetes. J Diabetes Complications. 2017;31(4):735–41. https://doi.org/10.1016/j.jdiacomp.2016.12.015.
Article PubMed PubMed Central Google Scholar
Wild D, von Maltzahn R, Brohan E, Christensen T, Clauson P, Gonder-Frederick L. A critical review of the literature on fear of hypoglycemia in diabetes: implications for diabetes management and patient education. Patient Educ Couns. 2007;68(1):10–5. https://doi.org/10.1016/j.pec.2007.05.003.
Hu S, Yang H, Chen Z, et al. Clinical outcome and cost-effectiveness analysis of CSII Versus MDI in Children and adolescent with type 1 diabetes Mellitus in a Public Health Care System of China. Front Endocrinol (Lausanne). 2021;12:604028. https://doi.org/10.3389/fendo.2021.604028.
Al Shaikh A, Al Zahrani AM, Qari YH, et al. Quality of life in children with diabetes treated with insulin pump compared with multiple daily injections in Tertiary Care Center. Clin Med Insights Endocrinol Diabetes. 2020;13:1179551420959077. https://doi.org/10.1177/1179551420959077.
Article PubMed PubMed Central Google Scholar
Rosner B, Roman-Urrestarazu A. Health-related quality of life in paediatric patients with type 1 diabetes mellitus using insulin infusion systems. A systematic review and meta-analysis. PLoS ONE. 2019;14(6):e0217655. https://doi.org/10.1371/journal.pone.0217655.
Article CAS PubMed PubMed Central Google Scholar
Barnard KD, Lloyd CE, Skinner TC. Systematic literature review: quality of life associated with insulin pump use in type 1 diabetes. Diabet Med. 2007;24(6):607–17. https://doi.org/10.1111/j.1464-5491.2007.02120.x.
Article CAS PubMed Google Scholar
Badhiwala JH, Karmur BS, Wilson JR. Propensity score matching: a powerful Tool for analyzing Observational Nonrandomized Data. Clin Spine Surg. 2021;34(1):22–4. https://doi.org/10.1097/BSD.0000000000001055.
Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41–55.
Ishii H, Yamamoto T, Ohashi Y. Development of insulin therapy related quality-of-life measure (ITR-QOL). J Japan Diab Soc. 2001;44:9–15.
Liu WW, Zhao LQ. A study on the reliability and validity of the quality of Life Scale for patients receiving insulin treatment. Chin J Nurs. 2009;44(9):849–51. https://doi.org/10.3761/j.issn.0254-1769.2009.09.033.
Cox DJ, Irvine A, Gonder-Frederick L, Nowacek G, Butterfield J. Fear of hypoglycemia: quantification, validation, and utilization. Diabetes Care. 1987;10(5):617–21. https://doi.org/10.2337/diacare.10.5.617.
Article CAS PubMed Google Scholar
Mu Chun B, Di, Xing Qiuling. The reliabilityand validityof Chinese Version of Hypoglycemia Fear Survey H-Worry scale (CHFSH-WS) in type2 diabetes mellitus. Chin J Prac Nurs. 2015;31(3):198–201. https://doi.org/10.3760/cma.j.issn.1672-7088.2015.03.013.
Gomez-Peralta F, Choudhary P, Cosson E, Irace C, Rami-Merhar B, Seibold A. Understanding the clinical implications of differences between glucose management indicator and glycated haemoglobin. Diabetes Obes Metab. 2022;24(4):599–608. https://doi.org/10.1111/dom.14638.
Article CAS PubMed Google Scholar
Pickup JC. Management of diabetes mellitus: is the pump mightier than the pen? Nat Rev Endocrinol. 2012;8(7):425–33. https://doi.org/10.1038/nrendo.2012.28.
Article CAS PubMed Google Scholar
William J, McCluskey J, Gleeson N. RT-CGM in conjunction with CSII vs MDI in optimizing glycaemic control in T1DM: systemic review and meta-analysis. Endocrinol Diabetes Metab. 2022;5(2):e00324. https://doi.org/10.1002/edm2.324.
Article CAS PubMed PubMed Central Google Scholar
Pozzilli P, Battelino T, Danne T, Hovorka R, Jarosz-Chobot P, Renard E. Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics. Diabetes Metab Res Rev. 2016;32(1):21–39. https://doi.org/10.1002/dmrr.2653.
Article CAS PubMed Google Scholar
Alsaleh FM, Smith FJ, Taylor KM. Experiences of children/young people and their parents, using insulin pump therapy for the management of type 1 diabetes: qualitative review: experiences of using insulin pumps. J Clin Pharm Th. 2012;37(2):140–7. https://doi.org/10.1111/j.1365-2710.2011.01283.x.
留言 (0)